肝细胞p62抑制mTORC1激活伴自噬缺陷小鼠的胆管反应与肿瘤发生
该研究在小鼠中构建肝特异性Atg5、Tsc1单敲及双敲模型,发现敲除Atg5可抑制L-Tsc1 KO小鼠肝肿瘤发生但增加死亡率并伴胆管反应增强;敲除p62可逆转胆管反应和代谢重编程及死亡率,却通过激活致癌信号通路促进肿瘤发生;Nrf2敲除改善胆管反应和代谢重编程及生存且无肿瘤形成。
要点
- 肝细胞p62缺失逆转自噬缺陷伴mTORC1激活小鼠的胆管反应和代谢重编程但促进肿瘤发生
- Nrf2敲除改善L-Atg5/Tsc1双敲小鼠胆管反应、代谢重编程和生存且无肿瘤形成
- 部分人肝细胞癌中观察到p62降低和mTOR活性增高
核心结论
- 肝细胞p62具有抑制肿瘤发生及调控肝细胞再生和代谢重编程的新功能。
研究设计与样本
- 研究使用肝特异性Atg5敲除、Tsc1敲除及双敲小鼠,并进一步构建p62和Nrf2敲除小鼠,饲养至12个月进行生化和组织学分析。
主要发现
- 在L-Tsc1 KO小鼠中敲除Atg5抑制肝肿瘤发生但增加死亡率,并伴随胆管反应显著增强、肝细胞变性和代谢重编程。
- 敲除p62可逆转L-Atg5/Tsc1双敲小鼠的胆管反应、肝细胞变性、代谢重编程及死亡率,但通过激活致癌信号通路促进肝肿瘤发生。
- 敲除Nrf2显著改善L-Atg5/Tsc1双敲小鼠的胆管反应、增加肝细胞数量、改善代谢重编程和生存,且无肿瘤形成。
- 部分人肝细胞癌中观察到p62降低和mTOR活性增高。
临床怎么用
- 提示p62/Sqstm1在mTORC1激活和自噬缺陷相关肝肿瘤发生中具有抑癌功能,可能为肝癌防治提供新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Either activation of mTORC1 due to loss of Tsc1 (tuberous sclerosis complex 1) or defective hepatic autophagy due to loss of Atg5 leads to spontaneous liver tumorigenesis in mice. The purpose of this study was to investigate the mechanisms by which autophagy contributes to the hepatic metabolic changes and tumorigenesis mediated by mTORC1 activation. METHODS: Atg5 Flox/Flox (Atg5F/F) and Tsc1F/F mice were crossed with albumin-Cre mice to generate liver-specific Atg5 knockout (L-Atg5 KO), L-Tsc1 KO and L-Atg5/Tsc1 double KO (DKO) mice. These mice were crossed with p62/Sqstm1F/F (p62) and whole body Nrf2 KO mice to generate L-Atg5/Tsc1/p62 and L-Atg5/Tsc1-Nrf2 triple KO mice. These mice were housed for various periods up to 12 months, and blood and liver tissues were harvested for biochemical and histological analysis RESULTS: Deletion of Atg5 in L-Tsc1 KO mice inhibited liver tumorigenesis but increased mortality and was accompanied by drastically enhanced hepatic ductular reaction (DR), hepatocyte degeneration and metabolic reprogramming. Deletion of p62 reversed DR, hepatocyte degeneration and metabolic reprogramming as well as the mortality of L-Atg5/Tsc1 DKO mice, but unexpectedly promoted liver tumorigenesis via activation of a group of oncogenic signaling pathways. Nrf2 ablation markedly improved DR with increased hepatocyte population and improved metabolic reprogramming and survival of the L-Atg5/Tsc1 DKO mice without tumor formation. Decreased p62 and increased mTOR activity were also observed in a subset of human hepatocellular carcinomas. CONCLUSIONS: These results reveal previously undescribed functions of hepatic p62 in suppressing tumorigenesis and regulating liver cell repopulation and metabolic reprogramming resulting from persistent mTORC1 activation and defective autophagy. LAY SUMMARY: Metabolic liver disease and viral hepatitis are common chronic liver diseases and risk factors of hepatocellular carcinoma, which are often associated with impaired hepatic autophagy and increased mTOR activation. Using multiple genetically engineered mouse models of defective hepatic autophagy and persistent mTOR activation, we dissected the complex mechanisms behind this observation. Our results uncovered an unexpected novel tumor suppressor function of p62/Sqstm1, which regulated liver cell repopulation, ductular reaction and metabolic reprogramming in liver tumorigenesis.
引用
- Chao X, Wang S, Fulte S, et al. Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagy. J Hepatol. 2021. PMID: 34710483. doi:10.1016/j.jhep.2021.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。